Tuesday 18 December 2018

Trial may uncover new diagnostics and treatment option for cardiovascular disease

(Wayne State University - Office of the Vice President for Research) A Wayne State University research team, in collaboration with Arterez, LLC, a Michigan-based biopharmaceutical company, has commenced a clinical study to identify the 'fingerprint' and diagnostic accuracy of Arterez' seven patent-pending glycocalyx biomarkers in relation to arterial disease, specifically hypertension and heart failure. The collaboration aims to help address the rising number of deaths from cardiovascular disease.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2R1BHEt

No comments:

Post a Comment